LYMPHANGIOMATOSIS & GORHAMS DISEASE ALLIANCE INC (EIN 261224181) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2007

Legal Domicile

Principal Officer

MICHAEL KELLY

Phone

2622278453

Tax Period

2023-07-01 to 2024-06-30

LYMPHANGIOMATOSIS & GORHAMS DISEASE ALLIANCE INC, founded in 2007, is a small nonprofit in the Diseases & Disorders sector that reported $271K in total revenue in fiscal year 2023. Revenue surged 123% from the prior year, signaling strong growth momentum. Expenses of $311K exceeded revenue, resulting in a 15% operating deficit.

Mission

WORLDWIDE PATIENT SUPPORT PROGRAM WHICH INCLUDES A PATIENT REGISTRY, A WEBSITE WITH RARE DISEASE INFORMATION AND PATIENT DISCUSSION FORUM.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $251,887

Program Service Revenue $13,500

Investment Income $5,655

Other Revenue $0

TOTAL REVENUE $271,042

Expense Breakdown

Grants Paid $79,247

Salaries & Benefits $86,831

Fundraising Expenses $24,191

Program Expenses $241,939

Other Expenses $144,647

TOTAL EXPENSES $310,725

Year-over-Year Comparison

	2023	2022	Change
Revenue	$271,042	$121,403	+1.2%
Expenses	$310,725	$280,940	+0.1%
Net Income	$-39,683	$-159,537	-0.8%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$106,711

Total Directors

$70,781

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
LOUISE MURGIA	DIRECTOR OF OPERATIONS	40	Officer Director	$70,781	$0	$70,781
MICHAEL KELLY	EXECUTIVE DIRECTOR	20	Officer	$35,930	$0	$35,930
TIFFANY FERRY	BOARD MEMBER	2	Director	$0	$0	$0
MITCH MAERSCH	BOARD MEMBER	2	Director	$0	$0	$0
SCOTT GOLDFARB	BOARD MEMBER	2	Director	$0	$0	$0
KEVIN MARTIN	BOARD MEMBER	2	Director	$0	$0	$0
SEAN CHASTAIN	BOARD MEMBER	2	Director	$0	$0	$0
SCOTT WEISNER	PRESIDENT	2	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$271,042	$310,725	$386,253	$-39,683
2022	$321,718	$319,777	$579,142	$1,941
2021	$323,008	$211,390	$662,607	$111,618
2020	$320,054	$106,049	$552,913	$214,005

LYMPHANGIOMATOSIS & GORHAMS DISEASE ALLIANCE INC